Loading...
Loading...
Browse all stories on DeepNewz
VisitWhich major medical organization will first update guidelines based on Brodin's findings by September 30, 2025?
American Medical Association (AMA) • 25%
World Health Organization (WHO) • 25%
Centers for Disease Control and Prevention (CDC) • 25%
Other • 25%
Official announcements and publications from medical organizations
Nature Study by Petter Brodin Finds Testosterone Therapy Alters Immune System in Trans Men
Sep 4, 2024, 03:24 PM
Recent research published in Nature reveals that gender-affirming testosterone therapy in trans men results in significant changes to their immune systems, making them more similar to cisgender men. The study, led by Petter Brodin and colleagues, highlights that testosterone therapy reduces type I interferon and enhances TNF signatures. This research provides insights into why males are more vulnerable to severe infections, such as acute COVID-19, while females are more prone to autoimmune diseases like SLE and MS. The findings, published in Nature, could help scientists better understand sex differences in immune responses among both cisgender and transgender individuals.
View original story
World Health Organization (WHO) • 25%
Centers for Disease Control and Prevention (CDC) • 25%
National Institutes of Health (NIH) • 25%
Other • 25%
WHO • 25%
CDC • 25%
Other • 25%
None • 25%
Royal College of Physicians • 25%
American Medical Association • 25%
World Health Organization • 25%
Other/None • 25%
American Cancer Society • 25%
World Health Organization • 25%
Centers for Disease Control and Prevention • 25%
Other • 25%
Yes • 50%
No • 50%
CDC • 25%
WHO • 25%
American Medical Association • 25%
Other • 25%
CDC • 25%
WHO • 25%
European Medicines Agency • 25%
Other • 25%
Yes • 50%
No • 50%
WHO • 25%
CDC • 25%
EMA • 25%
Other • 25%
World Health Organization (WHO) • 25%
International Atomic Energy Agency (IAEA) • 25%
United Nations (UN) • 25%
Greenpeace • 25%
Yes • 50%
No • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Sex differences in disease susceptibility • 25%
Gender-affirming therapies • 25%
Other • 25%
Immune response studies • 25%